Clinical IQ Savings Analysis | Discover Your Blood Utilization Opportunity | hc1

Uncover Your
Blood and Anemia
Management Savings

Most health systems leave millions on the table each year in unnecessary transfusions and untreated anemia. Our Clinical IQ™ Savings Analysis shows you exactly where your organization stands and what it could save.

15-25% Typical blood acquisition
cost reduction
1 Full Day Average LOS reduction
per treated patient
350+ Healthcare organizations
partnerships

What you'll receive

Blood utilization savings estimate by product type
Anemia management and LOS reduction opportunity
IV iron infusion revenue projection
Benchmark comparison against peer health systems
No commitment. No cost. A 30-minute discovery call using your data.

Clinical IQ™ Savings Analysis

Complimentary Discovery Call

Fill Out Form Below
Custom blood utilization savings estimate (RBC, platelets, plasma)
Anemia management and LOS reduction opportunity by procedure
IV iron infusion revenue projection and peer benchmarks
Your information is kept private and never shared with third parties.

Two major cost and revenue levers
hiding in your data

Most health systems have never seen a side-by-side view of both. Our team has spent years building the benchmarks to calculate it precisely.

Blood Utilization Cost Reduction

Unnecessary transfusions drive up blood acquisition costs, expose patients to avoidable risk, and fly under the radar of most supply chain analytics. Clinical IQ identifies where over-utilization is happening and what it is costing you across RBCs, platelets, and plasma.

15-25% Typical reduction in blood acquisition costs seen by hc1 partner health systems

Anemia Management and LOS Reduction

Untreated anemia before surgery extends length of stay, increases complications, and adds significant cost per patient episode. By proactively identifying and treating anemia ahead of surgery, health systems cut average LOS and free up capacity while generating new infusion revenue.

1 Day Average LOS reduction per surgical patient when anemia is proactively treated (avg untreated: 4.5 days)

Product-Level Breakdown: RBC, Platelets, Plasma

Blood product costs are not equal. Your analysis breaks down unnecessary utilization by product type, so your team can prioritize the highest-impact interventions first and track progress against evidence-based transfusion thresholds.

Data-Driven Savings model built on your volume and benchmark data, not generic industry averages

IV Iron Infusion Revenue Opportunity

Proactive anemia treatment creates a new revenue stream. When patients are identified early and treated with IV iron infusions, health systems generate new margin while reducing downstream transfusion costs. Your analysis will project this opportunity based on your surgical patient volume.

Dual ROI Cost savings from LOS reduction and new revenue from infusion services

We assess anemia opportunity
across your highest-volume procedures

Anemia impacts length of stay differently across procedure types. Your analysis is segmented by procedures so you can see where the biggest opportunities are.

01

Joint Replacement

Orthopedic surgeries carry high anemia prevalence and significant LOS impact when untreated

02

Colectomy

Colorectal patients often present with baseline anemia that goes undetected pre-operatively

03

Cardiac (Invasive)

Complex cardiac procedures see compounding risk when patients enter surgery anemic

04

Nephrectomy

Renal patients have elevated chronic anemia rates requiring proactive screening protocols

05

Obstetrics

Maternal anemia affects 1 in 4 pregnancies and drives postpartum transfusion rates

06

Spinal Fusion

Complex spinal procedures carry elevated blood loss risk and significant transfusion exposure

See the opportunity before you commit to anything

Your Clinical IQ Savings Analysis is built from your own data, not generic assumptions. In a 30-minute call, our team works through your annual blood product volumes and surgical mix to produce a custom savings model you can take back to leadership.

Get My Free Analysis
Clinical IQ™ Savings Analysis - Sample Output
Real Opportunity

Estimated Annual Opportunity

$0

RBC Utilization Reduction $820K
Platelet Optimization $310K
Plasma Reduction $145K
Anemia LOS Reduction $1.2M
IV Iron Infusion Revenue $480K

Projected Example for a 400-bed health system. Your analysis is customized using your actual blood product volumes and DRG procedure volumes.

Simple. Fast. No commitment.

Get a clear picture of your potential savings in minutes.

1

Submit Your Info

Complete the short form on this page. No data upload required at this stage, just your contact information and organization name.

2

30-Minute Discovery Call

Our clinical experts schedule a brief call to gather the inputs needed including blood product volumes, DRG procedure volumes, and current transfusion initiatives.

3

Receive Your Analysis

We build and deliver a custom savings model showing your specific blood utilization and anemia management opportunity.

Trusted by leading health systems

350+ Healthcare organizations partnerships
50M+ Patients impacted
25% Average decrease in unnecessary transfusions
40% Reduction in unnecessary testing

Our clients

Sonora Quest Laboratories
Jefferson Health
Bon Secours Mercy Health
Stormont Vail
Memorial Healthcare
Advent Health

Ready to see your number?

Get a custom savings estimate built on your data, at no cost and no obligation.

Get My Free Clinical IQ Analysis